These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. New HLA--D specificity included in Dw7. Möller E; Lindblom B Tissue Antigens; 1978 May; 11(5):489-91. PubMed ID: 80837 [TBL] [Abstract][Full Text] [Related]
30. Contribution of the MHC region to the familial risk of coeliac disease. Bevan S; Popat S; Braegger CP; Busch A; O'Donoghue D; Falth-Magnusson K; Ferguson A; Godkin A; Hogberg L; Holmes G; Hosie KB; Howdle PD; Jenkins H; Jewell D; Johnston S; Kennedy NP; Kerr G; Kumar P; Logan RF; Love AH; Marsh M; Mulder CJ; Sjoberg K; Stenhammer L; Walker-Smith J; Marossy AM; Houlston RS J Med Genet; 1999 Sep; 36(9):687-90. PubMed ID: 10507725 [TBL] [Abstract][Full Text] [Related]
31. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Mearin ML; Biemond I; Peña AS; Polanco I; Vazquez C; Schreuder GT; de Vries RR; van Rood JJ Gut; 1983 Jun; 24(6):532-7. PubMed ID: 6602084 [TBL] [Abstract][Full Text] [Related]
32. Influence of HLA-DQ2 and DQ8 on severity in celiac Disease. Biagi F; Bianchi PI; Vattiato C; Marchese A; Trotta L; Badulli C; De Silvestri A; Martinetti M; Corazza GR J Clin Gastroenterol; 2012 Jan; 46(1):46-50. PubMed ID: 21694611 [TBL] [Abstract][Full Text] [Related]
33. Coeliac disease and HLA: a family study. Robinson BN; Roberts DF; Mather BA; Nelson R; Rowlatt AS J Immunogenet; 1980 Oct; 7(5):381-91. PubMed ID: 7430678 [TBL] [Abstract][Full Text] [Related]
34. TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. Rossi E; Basso D; Zambon CF; Navaglia F; Greco E; Pelloso M; Artuso S; Padoan A; Pescarin M; Aita A; Bozzato D; Moz S; Cananzi M; Guariso G; Plebani M PLoS One; 2015; 10(4):e0123244. PubMed ID: 25915602 [TBL] [Abstract][Full Text] [Related]
35. HLA system. Phenotypic and gene frequencies in celiac and healthy subjects from the same geographical area. Ruiz del Prado MY; Olivares López JL; Lázaro Almarza A; Lasierra Díaz MP Rev Esp Enferm Dig; 2001 Feb; 93(2):106-13. PubMed ID: 11471223 [TBL] [Abstract][Full Text] [Related]
36. Use of HLA marker associations and HLA haplotype linkage to estimate disease risks in families with gluten-sensitive enteropathy. Lin HJ; Rotter JI; Conte WJ Clin Genet; 1985 Sep; 28(3):185-98. PubMed ID: 3877582 [TBL] [Abstract][Full Text] [Related]
37. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Contreas G; Valletta E; Ulmi D; Cantoni S; Pinelli L Acta Paediatr; 2004 May; 93(5):628-32. PubMed ID: 15174785 [TBL] [Abstract][Full Text] [Related]
38. HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations. Marcusson J; Möller E Tissue Antigens; 1979 Oct; 14(4):279-95. PubMed ID: 94702 [TBL] [Abstract][Full Text] [Related]
39. The prevalence of celiac disease among family members of celiac disease patients. Dolinsek J; Urlep D; Karell K; Partanen J; Micetić-Turk D Wien Klin Wochenschr; 2004; 116 Suppl 2():8-12. PubMed ID: 15506303 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance and cost-effectiveness of HLA genotyping in children with Type 1 diabetes mellitus in screening for coeliac disease in the Netherlands. Elias J; Hoorweg-Nijman JJ; Balemans WA Diabet Med; 2015 Jun; 32(6):834-8. PubMed ID: 25546232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]